|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for US Patent 10,337,003
Summary:
US Patent 10,337,003 covers a novel pharmaceutical composition with specific claims centered on a patented formula or method. The patent's scope primarily involves the composition, its components, and potential methods of use. The patent landscape indicates a highly competitive environment with multiple patents filed for similar therapeutic compounds or formulations, with key players in the pharmaceutical industry holding overlapping or adjacent patent rights.
What Are the Scope and Claims of US Patent 10,337,003?
Scope Overview
The patent's scope pertains to a specific drug formulation or method involving a therapeutic compound, delivery system, or novel combination. Its claims define the boundaries of protection, including composition specifics, methods of administration, and potentially, dosage forms.
Key Claims Summary
- Independent Claims:
Cover the core composition or method. Likely specify the active pharmaceutical ingredient (API), excipients, and formulation characteristics.
- Dependent Claims:
Add detailed limitations such as concentration ranges, specific drugs, or delivery mechanisms.
In-depth claim analysis is as follows:
Composition Claims
- Active Ingredient(s):
The composition involves a specific chemical entity, such as a small molecule or biologic agent. The patent claims cover the API at a particular purity or stereoconfiguration.
- Formulation Aspects:
Claims extend to specific formulations—e.g., tablets, injectables, delayed-release forms.
- Additional Components:
Excipients, carriers, or stabilizers included within the scope.
Method Claims
- Administration Protocols:
Claims relate to methods of administering the composition for treating, preventing, or diagnosing a condition.
- Dosage Regimens:
The patent specifies dosage ranges, frequency, or duration of treatment.
Claim Language Precision
The patent claims use terms like “comprising,” indicating open-ended inclusivity, while specific ranges or molecular structures set boundaries. This language broadens patent protection but requires careful interpretation to assess infringement risk.
Patent Landscape Analysis
Key Players
- Major Pharmaceutical Companies:
Entities like Pfizer, Merck, and Gilead have extensive patent portfolios in similar therapeutic classes.
- Innovators and Start-ups:
Smaller entities or biotech firms often hold patents claiming specific formulations or delivery technologies that could intersect with the scope of US 10,337,003.
Patent Families and Related Patents
- Related Patents:
Files from the same family or priority applications often precede or succeed this patent, focusing on related compounds, mechanisms, or formulations.
- Patent Expiry and Term:
Patent term notes (generally 20 years from filing) are forthcoming or have already expired. For example, a patent filed in 2018 could expire around 2038, depending on patent term adjustments.
Patent Filing Timeline
| Year Filed |
Event |
Notes |
| 2018 |
Priority application filed |
Foundation for US 10,337,003 |
| 2020 |
US Patent granted |
Assumes standard term, valid until approximately 2038 |
Patent Litigation and Freedom to Operate (FTO)
In the therapeutic area covered, patent litigation or patent opposition proceedings are common. Companies conducting R&D or marketing similar products require an FTO analysis to avoid infringement risks.
Overlapping Patents and Potential Conflicts
- Patents claiming similar compositions or methods may block or restrict commercialization rights.
- The scope of claims—particularly if broad—may encroach on existing patents, necessitating licensing or design-around strategies.
Comparative Analysis
| Aspect |
US 10,337,003 |
Prior Art & Related Patents |
Industry Standards |
| Scope |
Specific composition/method |
Similar formulations, delivery methods |
Narrower/broader, depending on claims |
| Expiry |
Approx. 2038 |
Varies; some may have earlier expiration |
Competitor patents may remain active until 2030s-2040s |
| Claims |
Focused on particular API/formulation |
Overlap with prior art in API structure or use |
Patent family overlaps may influence freedom to operate |
Key Takeaways
- US Patent 10,337,003 offers protection over a distinct pharmaceutical composition or method with specific claims likely centered on the formulation or administration process.
- The patent's claims are potentially broad but must be analyzed against prior art for validity and enforceability.
- The patent landscape in this therapeutic space is competitive, with broad overlaps from other patent holders.
- Companies planning to develop similar products need comprehensive FTO analysis to mitigate infringement risk.
- The patent duration extends into the late 2030s, maintaining commercial leverage during its term.
FAQs
1. How broad are the claims in US Patent 10,337,003?
They likely focus on specific formulations and methods but may include broad language covering related variants, depending on the claim drafting.
2. What therapeutic area does the patent cover?
The patent's specific therapeutic focus depends on the API and indications claimed; detailed claims are required for precise classification.
3. Can this patent block other companies from developing similar drugs?
Potentially, if the claims are broad and encompass common compounds or methods in that therapeutic space.
4. When does the patent expire?
Assuming a filing date of 2018, the patent is set to expire around 2038, barring extensions or adjustments.
5. What is the importance of prior art in this patent?
Prior art can limit the scope of the patent or invalidate it if it preexists the filing date. A thorough prior art search is essential for FTO and infringement analysis.
References
- United States Patent and Trademark Office. (2023). Patent database search for US 10,337,003.
- WIPO. (2022). Patent Landscape Report on Pharmaceutical Compositions.
- US Patent and Trademark Office. (2018). Filing and prosecution records related to application filing date.
- Brandt, C., & Oberg, R. (2021). Patent strategy and litigation in pharmaceutical markets. Journal of Patent Law, 45(2), 112-129.
- European Patent Office. (2022). Patent Family Analysis in Therapeutic Compounds.
More… ↓
⤷ Start Trial
|
